Skip to main content
Premium Trial:

Request an Annual Quote

UK Research Council Signs ELIXIR Consortium Agreement

Premium

The UK's Biotechnology and Biological Sciences Research Council, BBSRC, has signed the European Consortium Agreement, an understanding that forms the legal basis for the European Life Science Infrastructure for Biological Information consortium, establishes its organizational structure, and commits signatories to providing support for the project.

In a statement, Douglas Kell, BBSRC's chief executive, said that signing the agreement shows BBSRC's and, by extension, the UK's "commitment to a successful response to the informatics opportunities that are available in order to achieve maximum scientific impact for the benefit of us all." He noted that "without significant investment in bioinformatics services and improved skills training throughout Europe, we will rapidly lose the capacity to provide the research community with access to the treasure trove of public data in the life sciences."

The ECA will come into effect once it has been ratified by five countries. This is expected to happen by late 2013. The agreement has also been signed by the European Molecular Biology Laboratory Council. It ratified the ECA during a meeting in Heidelberg, Germany last June.

Filed under

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.